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Abstract
Background: Thoracic surgery appears to be the treatment of choice for many lung cancers. Nevertheless, depending on the
type of surgery, the chest area may be painful for several weeks to months after surgery. This painful state has multiple physical
and psychological implications, including respiratory failure, inability to clear secretions by coughing, and even anxiety and
depression that have negative effects on recovery.
Objective: The aim of this study is to evaluate the effect of a neurofeedback-based intervention on controlling acute post-surgery
pain and improving long-term recovery in patients who undergo thoracotomy for lung resection for non-small cell lung cancer
(NSCLC) at an academic oncologic hospital.
Methods: This study will be based on a 2-parallel group randomized controlled trial design, intervention versus usual care, with
multiple in-hospital assessments and 2 clinical, radiological, and quality of life follow-ups. Participants will be randomized to
either the intervention group receiving a neurofeedback-based relaxation training and usual care, or to a control group receiving
only usual care. Pain intensity is the primary outcome and will be assessed using the Numeric Pain Rating Scale (NRS) in the
days following the operation. Secondary outcomes will include the effect of the intervention on hospital utilization for pain crisis,
daily opioid consumption, anxiety, patient engagement, blood test and chest x-ray results, and long-term clinical, radiological,
and quality of life evaluations. Outcome measures will be repeatedly taken during hospitalization, while follow-up assessments
will coincide with the follow-up visits. Pain intensity will be assessed by mixed model repeated analysis. Effect sizes will be
calculated as mean group differences with standard deviations.
Results: We expect to have results for this study before the end of 2016.
Conclusions: The proposed innovative, neurofeedback- and relaxation-based approach to support post-surgery pain management
could lead to significant improvements in patient short and long-term outcomes.
(JMIR Res Protoc 2015;4(2):e52)   doi:10.2196/resprot.4251
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Introduction
Background
Lung cancer has been the most common cancer worldwide since
1985, both in terms of incidence and mortality [1-3], and it is
among the top five most frequently diagnosed cancers in Italy
[4]. Thoracic surgery appears to be the treatment of choice for
many lung cancers. Nevertheless, depending on the type of
surgery, the chest area may be painful for several weeks to
months after surgery. Indeed, after a thoracotomy, patients often
suffer from a persistent pain [5-7] due to the skin incision or
deeper tissue injuries, costovertebral joint disruption, resection
or fracture of ribs or sternum, and further irritation of the pleura
by thoracostomy tubes [8,9]. This painful state has multiple
implications, including respiratory failure due to limiting
inspiration (because deep breathing requires stretching the
incision), or an inability to clear secretions by coughing [10].
Acute pain after surgery can become chronic and persist for
more than a year in 21%-67% of patients [11,12]. Moreover, a
lot of clinical and demographic factors can contribute to the
development of chronic postsurgical pain including
psychological conditions (anxiety or depression states), previous
surgery, other simultaneous pain, injuries of the chest wall,
youth, female gender, and increased levels of pain and analgesic
use in the perioperative period [13].
Cooley et al [14] have shown that a high level of post-operative
pain in lung cancer patients may exacerbate the fear that
movement or physical activity will worsen their condition. This
belief can lead to catastrophic appraisals of pain sensations that
promote a self-perpetuating cycle of behavioral avoidance,
hypervigilance, or distress symptoms [15-18], as well as reduced
social activity and global perceptions of decreased health [13].
Researchers investigating psychological aspects of persistent
pain have shown that the tendency to focus on pain and to
negatively evaluate one's ability to deal with pain, pain-related
anxiety, fear, and helplessness are associated with increased
pain, psychological distress, and physical disability [19].
Post-thoracotomy pain syndrome and its social consequences
have been also investigated by a nationwide study in Denmark
[20] that highlighted how partial nerve injury and general pain
hyperresponsiveness influence daily activities, even 12-36
months after surgery.
These data highlight the importance of finding effective, early
interventions in the presence of painful medical procedures
[17,19]. Several studies have demonstrated the effectiveness of
non-pharmacological techniques (eg, relaxation) that, in addition
to traditional treatments, are able to significantly reduce the
acute pain and distress associated with invasive medical
procedures [21,22]. Patients who undergo relaxation techniques
in different health care settings suffering from acute or chronic
pain have been shown to experience less pain compared to those
who only undergo traditional treatments [23-27]. In particular,
Syrjala et al [28] conducted a study to evaluate the effectiveness
of cognitive-behavioral techniques and relaxation in reducing
cancer-related pain and found that patients who received these
type of treatments, in addition to medical care, reported less
pain than the control groups. Although further analyses are
required [29], relaxation is a non-pharmacological intervention
that may control pain in cancer patients [30].
Many non-pharmacological interventions and interactive new
technologies, such as video games and virtual reality
environments, can greatly impact pain reduction. By playing a
game or being immersed in a virtual environment, users
experience an attentional competition between a highly salient
sensation (pain) and a consciously directed focus on some other
information processing activity [31]. The consequence is a
reduced pain perception [32-35], as well as observed changes
at a neuroanatomical level. Hoffman et al [36,37] conducted an
fMRI study to monitor the brain activity in healthy subjects
receiving thermal brain stimulation and showed that virtual
reality alone significantly reduced the worst pain and pain
unpleasantness, as well as pain-related brain activity in the
insula and thalamus. Moreover, combined opioid plus virtual
reality exposure reduced pain reports more effectively than did
opioid alone on all subjective pain measures [38]. These studies
demonstrate that, by distracting subjects from a highly salient
sensation of pain, virtual reality may change not only the
psychological perception of pain, but also the neuroanatomical
networks involved in its modulation [39].
Serious games and virtual realities have been used in different
contexts to modulate pain perception. In a recent review, Keefe
et al [40] affirmed that virtual reality-based behavioral programs
can be used to reduce acute or chronic pain among patients
undergoing different medical interventions and rehabilitation
programs, such as burn wound care, needle-related procedures,
intravenous placement, dental treatments, or postoperative pain.
In addition, actively participating in distracting tasks have effects
not only on concurrent pain experiences, but long term as well,
such as the vividness of memories associated with a traumatic
event [33], functional performance, energy level, and time of
recovery [34].
Since relaxation, distraction, and new technologies have
beneficial effects on pain reduction, we propose to implement
a research protocol that, by merging these factors, could help
post-operative lung cancer patients to cope with acute pain
generated by surgery. The technology that best suits our aim is
based on the brain-computer interface (BCI) method, which
enables a quick measure of brain activity while providing a
neurofeedback (based on simple visual or auditory stimuli, or
complex virtual environments) to help the user modulate her/his
brain activity to accomplish her/his intents [41]. One of the most
user-friendly, simple-to-use and low-cost BCI devices on the
market is produced by NeuroSky, who sell a non-invasive, dry
biosensor that can read electrical activity in the brain to
determine attention and relaxation states. The device, called
MindWave, is a portable electro encephalogram (EEG)
developed to capture neural activity using three dry electrodes
(located beneath the ears and the forehead), and decode them
by applying specific algorithms. The MindWave device provides
information on a user’s delta, theta, alpha, beta, and gamma
brainwave band power levels [42]. The power levels can be
interpreted by comparing them to themselves, and with each
other, to determine relative quantity and temporal fluctuations
[43]. Despite that the MindWave device cannot be used to
deeply and precisely monitor the EEG brain activity, it is
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effective in recording the level of attention and relaxation of
the user through the analysis of brain wave synchronization and
desynchronization [44]. Moreover, the MindWave device works
with engaging applications that help users to improve their
abilities to reach attentive or relaxed states by giving them
specific visual and auditory feedbacks in response to their brain
activity.
We believe that the MindWave and its associated applications
can benefit patients in the following ways (1) train them in
relaxation techniques, (2) engage them in active tasks, and (3)
by receiving motivation neurofeedback, push them to
continuously improve their performance. Moreover, due to its
ease of use, MindWave can be used by patients the precise
moments they are experiencing acute pain.
Our goal is to help patients with lung cancer post-operative
acute pain gain better control of their symptoms using this
innovative, neurofeedback-based pain-control strategy. We
hypothesize that patients randomized to receive the intervention
will have better pain outcomes, measured by pain intensity, and
better medical and psychological outcomes compared with
patients receiving usual care.
Primary Aim
Our primary aim is to evaluate the effect of neurofeedback on
pain control in patients with lung cancer who have been recently
operated on.
Secondary Aims
Secondary outcomes include evaluating the effects of
neurofeedback on (1) hospital utilization for pain crises, (2)
daily opioid consumption, (3) level of anxiety, (4) participants’
pattern of engagement with the MindWave tool, and (5) blood
test and chest x-ray results. Long-term outcomes also include
clinical, radiological, and quality of life evaluations at the 1 and
4 month follow-ups.
Methods
Trial Design
This study is based on a 2-parallel group randomized controlled
trial design (intervention vs usual care), with multiple in-hospital
assessments and 2 follow-ups (at 1 and 4 months) based on
clinical, radiological, and quality of life assessments. Follow-ups
will coincide with the follow-up visits. The research design is
shown in Figure 1.
Figure 1. Schematic representation of the trial design.
Participants
Participants included in this study will be recruited from the
thoracic surgery unit of the European Institute of Oncology
(IEO), Milan, Italy. To be considered eligible to participate,
patients must fulfill all of the following inclusion criteria (1)
they must be aged ≥18 years, (2) able to consent for self, (3)
have a primary diagnosis of non- small cell lung cancer
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(NSCLC), and (4) they must have undergone a thoracotomy for
lung resection <12 hours prior to the first pain assessment.
Ineligible patients will be defined as those who (1) have any
significant medical or psychiatric comorbidities (other than
depression or anxiety), (2) cognitive impediments that would
prevent them from being able to utilize the MindWave device,
(3) have a known history of substance abuse, and (4) are
simultaneously participating in any other research protocols
that may have an impact on pain intensity.
Recruitment Procedure
All patients who are planned to undergo a thoracotomy for lung
resection at the European Institute of Oncology, thoracic surgery
unit, are considered potential candidates for the present study.
Once admitted in the hospital, they will be screened by a trained
research assistant to verify their eligibility. Eligible patients
will be asked to sign the informed consent, and then randomly
assigned to the intervention or control groups. All participants
will be instructed to continue to receive medical care from
physicians as usual. Subjects included in the intervention arm
will be trained on the use of the technology and relaxation
technique prior to the operation by a research assistant. They
will also receive a MindSet device and tablet with the app Focus
Pocus installed on it, for the entire duration of hospitalization
(5 days).
Intervention
Framework for Intervention
This neurofeedback-based pain-management program is based
on the hypothesis that a relaxation training that provides users
an immediate feedback on their performance, as well as a playful
environment that moves the patient’s focus from the painful
sensation to a specific task can be effective in reducing acute
pain perception. In fact, the use of engaging and fun mini-games
encourages patients to exercise important psychological
processes that underlie their ability to control their own brain
responses and, consequently, their behavior.
Hardware and Software Equipment
Powered by NeuroSky’s Brainwave Technology, the Mindwave
headset is a slim, plastic device which fits comfortably, if not
unobtrusively, over the user’s left ear (see Figure 2). The
Mindwave mobile device uses a single sensor positioned on the
forehead to allow users to view their brainwaves in real-time.
The Mindwave headset picks up the brain’s electrical activity
and divides the signal by frequency into various types of waves,
allowing it to infer how relaxed (as measured by alpha and theta
waves) or concentrated (as measured by beta and gamma waves)
users are. In order to allow the headset to filter out non-brain
related electrical activity, a ‘reference’ contact, in the form of
a clip that attaches to the earlobe, is included. The MindWave
mobile device can connect, via bluetooth, to different devices,
and works with most modern operating systems (Windows X
or newer, Mac OS X 10.6.5 or newer) and mobile devices
running Android or iOS. Its battery life is rated at 8-10 hours
with a single AAA battery. Although it will take a minute or
two to adjust the headset the first time the user puts it on, setup
is relatively simple.
The MindWave mobile costs approximately 100 euros (€) and
comes bundled with many free and paid applications, but we
limited our choice to those available for the iPad tablet
specifically as it is one of the most confortable devices (in terms
of portability, weight, and usability) that can be used by
bedridden patients. After having tested all the existing iOS-based
apps, we opted for the one called “Focus Pocus-BrainControl”.
Focus Pocus is a mix of mini-games that uses live brain
electrical activity (ie, EEG) from the NeuroSky MindWave
device to alter the circumstances of the player. What happens
in the game depends on how relaxed the player is. Focus Pocus
attracted our attention for the following reasons (1) ease of use,
and has a very high-quality interface, yet is low in cost, (2) the
games are engaging and fun with a unifying theme, (3) provides
cognitive exercises designed by qualified experts, (4) can be
used anywhere and anytime without specific supervision, (5)
has been already used for scientific purposes [45,46], (6)
designed to provide an environment to practice the relaxation
skill (other than attention, impulse-control, and memory), (7)
can register the user’s training performance in terms of time of
use and achievements, and (8) rewards the users’ progress by
providing them behavior ratings at the end of each trial. With
respect to relaxation, for example, in the Focus Pocus
BrainControl games, the outcome of any relaxing experience
is the result of the content presented, the environment in which
it is presented, and the person’s readiness to learn. This readiness
depends on relaxation (a “state” factor) as well as being able to
control impulses and ignore internal (into the game) and external
(pain sensation) distractions. In order to guarantee improvement
in performance, the difficulty levels of the games are adaptive,
and can be adjusted on a per game basis to the performance of
the users.
A screenshot of one of the of the Focus Pocus games is shown
in Figure 3. A single electrode on the Neurosky headset (placed
on the forehead) is able to pick up a few simple and
characteristic brainwaves (created by activity in populations of
neurons), some that have been shown to be enriched when the
subject is awake and attentive (eg, beta waves), and some when
the subject is relaxed (eg, alpha waves). Neurosky has developed
algorithms to funnel these and other brain waves into measures
of “focus” and “meditation.” In particular, in this game, the
player needs to attain a certain level of meditation to win a duel
with an evil necromancer. The idea is that through these different
activities, the players would be exercising mental capacities
that would generalize outside the game (when they experience
acute pain, for example).
For the present protocol, 2 provided tablets and MindWave
mobile devices will be used at the same time on 2 different
patients. They will be given to the patients the day before the
operation and left at subjects' bedside for the duration of their
hospital stay. The nurses and the patients will be asked to take
care of the devices. The MindSet device and its sensor contact
points will be cleaned regularly with an alcohol-based cleaner
and a soft cloth included in the MindSet casing to prevent
cross-infection and to guarantee good signal quality.
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Figure 2. The MindWave mobile device.
Figure 3. A screenshot of one of the Focus Pocus mini-games.
JMIR Res Protoc 2015 | vol. 4 | iss. 2 | e52 | p.5http://www.researchprotocols.org/2015/2/e52/
(page number not for citation purposes)
Gorini et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Procedure
Training
Prior to the surgery (usually the day before), participants will
participate in an in-hospital intensive education (45-60 minutes)
training session when they are not yet experiencing
post-operative pain. During the training, an expert research
assistant will explain to each patient how, when, and for how
long the MindWave and the Focus Pocus app should be used.
After that, the patient will be encouraged to practice the use of
the tool by him/herself under the supervision of the research
assistant. Once the patients become autonomous with the device,
the training session will end, and the MindWave and tablet to
be used until their discharge from the hospital will be provided.
Intervention Group (Neurofeedback and Usual Care)
Patients included in the intervention arm will continue to receive
the standard care consisting of intercostal analgesia and
intravenous pain killers. In addition to it, they will be
encouraged to use the MindWave device to manage their pain
on-demand and every time they think they need it. During the
hospitalization period, patients assigned to the intervention
group will also be asked to evaluate their pain over the past 12
hours on a daily basis until their discharge from hospital.
Control Group
Subjects assigned to the control arm will receive only the
standard care. In adjunct, they will also be asked to evaluate
their pain over the past 12 hours, every day starting from the
operation until their discharge from hospital.
Randomization and Blinding
An independent researcher with no direct contact with the
participants will use a computer-generated randomization with
a 1:1 ratio and permutated blocks to optimize balance in each
treatment arm. Due to the nature of the study, participants, care
providers, and researchers cannot be blinded for the allocated
treatment. However, the data analysis will be blind, as all of the
patients receive a unique study code, under which their data is
stored in the database.
Outcome Evaluation
Data Collection Materials
We will assess one primary outcome and several secondary
outcomes. A number of validated instruments will be used to
assess the outcomes at multiple time points during the
hospitalization and follow-ups. The patients, both in the
treatment and in the control arms, will be asked to complete
them at specific time-points without the supervision of the
research assistants. Hospital nurses will be asked if they
completed all the outcome measures, as requested by the
protocol, at the end of each day. Demographic and clinical
information of each participant will be also collected.
Primary Outcome
The primary outcome measurement is pain intensity, measured
as a continuous outcome. It will be assessed quantitatively with
the Numeric Pain Rating Scale (NRS) [47]. The paper version
of the questionnaire will be self-administered. Participants will
be asked to complete it starting from 12 hours after the
operation, and every 12 hours during the entire hospitalization
period.
Secondary Outcomes
Several secondary outcomes will be measured at various time
points during the hospitalization (Textbox 1). Clinical,
radiological, and quality of life will be also assessed at the 2
follow-ups (at 1 and 4 months). The clinical and radiological
assessment is part of the post-operative routine. However, it
will be included in the outcome measures of the present protocol
because we expect that a reduction of pain immediately after
the operation can result in a better clinical and radiological
long-term outcome. Quality of life will be also assessed using
the EORTC QLQ-C30 (version 3.0).
Textbox 1. Secondary outcomes measured.
• The number of events in which the patient reports severe, uncontrolled, and causing distress pain that requires urgent and unplanned care visits
• Opioid consumption, measured quantitatively as oral morphine equivalent daily dose
• Anxiety, measured by the State-Trait Anxiety Inventory (STAI) scale
• The pattern of patient engagement with the MindWave tool, assessed quantitatively by the number and length of time each subject uses it (as
recorded by the software). Usability and satisfaction with the tool will be also investigated.
• A blood test and chest x-ray will be also performed at the end of the hospitalization period in order to determine if the intervention group shows
a better x-ray outcome and fewer infections, due to more physiotherapy because of reduced pain
Statistical Analysis
Sample Size Estimation
A sample size of 80 subjects, 40 per arm, is sufficient to detect
a difference of 1.5 between the two groups (control vs
intervention) in pain intensity scores, assuming equal standard
deviation of 2.5, using a two-tailed t test of difference between
means, with 80% power, and a 2-sided alpha of .05. Patients in
the experimental group who decide to never use the device
during hospitalization will be excluded from the study.
Statistical Analysis
Statistical analysis will be conducted with the SPSS Software,
version 22, with an alpha of .05 set a priori for all analyses.
Descriptive statistics will be used to summarize baseline
demographic characteristics by study arm. Continuous variables
will be compared between the two groups using a t test and
categorical variables will be compared using a chi-square test.
Pain intensity, our primary outcome, measured longitudinally,
will be assessed by mixed model analysis of variance with
treatment assignment as the between-group factor and time as
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the within-subject factor. Effect sizes will be calculated as mean
group differences with standard deviations. A similar approach
will be used to analyze continuous secondary outcomes while
categorical outcomes will be analyzed by chi-square tests.
Ethics and Informed Consent
The hospital internal ethical committee reviewed and approved
the study protocol. Upon meeting eligibility criteria, participants
will be informed about the study and asked to sign two copies
of the informed consent, one for them and the other for the study
team. During the enrollment visit and the entire duration of the
study, trained research assistants will be available to answer the
patients’ questions and to give them additional information.
Results
We expect to have results for this study before the end of 2016.
Discussion
Principal Findings
The idea to implement this protocol originated from the need
to find an on-demand, pain control strategy that helps lung
cancer patients to better tolerate acute pain that often arises in
the days immediately after surgery. A prompt reduction of pain
is fundamental to reduce the risk of respiratory failure and/or
the inability to clear secretions by coughing, as well as the
probability to develop long-term negative physical and
psychological conditions that can significantly interfere with a
full recovery.
Biofeedback-based training usually guarantees a persistent
learning, even when the machine-guided training ends up [48].
In other words, once users have learned to control their emotions
through the machine-guided relaxation training, they usually
become able to practice the relaxation techniques without any
external help. We argue that this can be applicable to the
neurofeedback method, such that, once learned to control pain
through relaxation with the help of the MindWave device,
patients can continue to use the techniques at home, without
the need for any external devices. Therefore, not only effective
immediately after the operation, the hospital training can become
a great resource to self-manage pain at home. Moreover, giving
patients the concrete opportunity to control their pain on-demand
is fundamental considering that the most acute pain tends to
appear during the night, when the effect of pharmacological
treatment decreases and the medical support is at a minimum.
Our main endpoint will serve to evaluate the immediate effect
of neurofeedback on pain control. If our results are positive,
this technique could be used in combination with traditional
pharmacological treatments to improve the patients’
post-operative experience, reduce the use of analgesic, and
improve long-term physical and psychological outputs.
A challenge of this research protocol is the use of neurofeedback
to reduce pain perception. While relaxation, virtual reality, and
gaming have been demonstrated to be effective in reducing pain,
there is no data on the efficacy of neurofeedback and related
applications. Nevertheless, we believe that neurofeedback has
great potential to reduce pain through relaxation for the
following three reasons. First, receiving feedback determined
by a specific mental activation can facilitate behavioral
modifications and learning of relaxation techniques. Second,
compared to traditional visual feedback, a more complex
feedback coming from a virtual game can encourage a greater
involvement of the patient, and consequently, distraction from
the painful sensation. Finally the MindWave system is a cheap,
user friendly device that can be easily used by patients without
the supervision of the research assistant.
Limitations
The main limitation of the present study is the number of
channels and poor precision of the MindWave device in
recording the user’s brainwaves. However, since brainwave
analyses are not the focus of this study, we do not consider it a
critical limitation. Future studies could make use of more
sophisticated devices that are currently being advertised but are
not yet available on the market.
Another limitation stems from our use of the Focus Pocus app
on adult cancer patients, as it was originally developed to train
children with specific attentive disorders. Even if the proposed
mini-games are suitable for adults, it would be useful, in the
future, to develop ad hoc apps tailored to adults’ preferences
and abilities.
Conclusions
To our knowledge, this is the first clinical trial evaluating the
impact of a neurofeedback-based intervention on pain
management. We hope that our results will lead to larger trials
to demonstrate more robust evidence. If our hypotheses are
confirmed, the proposed method can be applied to post-operative
patients and, in general, to patients suffering from acute pain
to reduce care costs and improve overall patient outcomes.
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